These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 360247)

  • 81. Doxepin versus chlordiazepoxide: a double-blind study on anxious outpatients.
    Kingstone E; Kolivakis T; Kossatz I
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):213-22. PubMed ID: 4985942
    [No Abstract]   [Full Text] [Related]  

  • 82. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Chlordiazepoxide and hostility in anxious outpatients.
    Rickels K; Downing RW
    Am J Psychiatry; 1974 Apr; 131(4):442-4. PubMed ID: 4592554
    [No Abstract]   [Full Text] [Related]  

  • 84. Symptomatic volunteers: another patient dimension for clinical trials.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol New Drugs; 1973; 13(2):89-98. PubMed ID: 4568298
    [No Abstract]   [Full Text] [Related]  

  • 85. Early treatment response in anxious outpatients treated with diazepam.
    Downing RW; Rickels K
    Acta Psychiatr Scand; 1985 Dec; 72(6):522-8. PubMed ID: 3909745
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Medication, anxiety reduction and patient report of significant life situation events.
    Lipman RS; Covi L; Derogatis LR; Rickels K; Uhlenhuth EH
    Dis Nerv Syst; 1971 Apr; 32(4):240-4. PubMed ID: 4932964
    [No Abstract]   [Full Text] [Related]  

  • 87. A DOUBLE BLIND TEST ON THE EFFECT OF CHLORDIAZPEPOXIDE (LIBRIUM) IN ANXIETY NEUROSIS.
    CHIEN CP; TSUANG MT; RIN H
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1963 Apr; 62():286-91. PubMed ID: 14132447
    [No Abstract]   [Full Text] [Related]  

  • 88. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial.
    Heo JY; Jeon HJ; Fava M; Mischoulon D; Baer L; Clain A; Doorley J; Pisoni A; Papakostas GI
    J Psychiatr Res; 2015 Mar; 62():56-61. PubMed ID: 25659187
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Phenaglycodol in anxiety: a controlled study.
    Rickels K; Csanalosi I; Gratch M; Gingrich RL; Kelly EA; Mirman MJ
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):23-31. PubMed ID: 806427
    [No Abstract]   [Full Text] [Related]  

  • 93. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Responders and nonresponders to chlordiazepoxide and placebo: a discriminant function analysis.
    Downing RW; Rickels K
    Prog Neuropsychopharmacol; 1980; 4(4-5):405-15. PubMed ID: 7012878
    [No Abstract]   [Full Text] [Related]  

  • 95. Predictors of chlordiazepoxide response in anxiety.
    Rickels K; Downing RW; Howard K
    Clin Pharmacol Ther; 1971; 12(2):263-73. PubMed ID: 4929080
    [No Abstract]   [Full Text] [Related]  

  • 96. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Benzodiazepines versus placebo for panic disorder in adults.
    Breilmann J; Girlanda F; Guaiana G; Barbui C; Cipriani A; Castellazzi M; Bighelli I; Davies SJ; Furukawa TA; Koesters M
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010677. PubMed ID: 30921478
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prediction of response to chlordiazepoxide and placebo in anxious outpatients: an attempt at replication.
    Downing RW; Rickels K
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Sep; 11(5):207-19. PubMed ID: 360247
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being.
    Kellner R; Rada RT; Andersen T; Pathak D
    Psychopharmacology (Berl); 1979 Aug; 64(2):185-91. PubMed ID: 115039
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Loxapine in neurotic anxiety: some modifiers of treatment response.
    Rickels K; Weise CC; Feldman H; Fee EA; Wiswesser G
    J Int Med Res; 1978; 6(3):180-5. PubMed ID: 348533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.